GOVERNMENT has launched construction of the ZAMVAX Vaccine Manufacturing Plant, a joint venture between IDC and Jijia Medical Technology aimed at reducing Zambia’s reliance on imported cholera vaccines. Industrial Development Corporation (IDC) Chief Executive Officer Cornwell Muleya says the first phase of the project, valued at US$24.1 million, will involve the construction of a facility designed to have a production capacity of up to 20 million vaccine doses per year. Chinese Ambassador to Zambia Han Jing says once completed, the facility will help Zambia reduce its reliance on imported vaccines and cut foreign currency spending. Meanwhile, Health Minister Professor Roma Chilengi says he hopes the facility will manufacture vaccines that meet the country’s domestic needs and also extend beyond Zambia...




